Jonathan A. Leff
2009
In 2009, Jonathan A. Leff earned a total compensation of $1.1M as Vice President and Chief Medical Officer at Halozyme Therapeutics.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $4,014 |
| Option Awards | $877,780 |
| Salary | $177,500 |
| Other | $4,963 |
| Total | $1,089,257 |
Leff received $877.8K in option awards, accounting for 81% of the total pay in 2009.
Leff also received $25K in bonus, $4K in non-equity incentive plan, $177.5K in salary and $5K in other compensation.
Rankings
In 2009, Jonathan A. Leff's compensation ranked 4,171st out of 9,885 executives tracked by ExecPay. In other words, Leff earned more than 57.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,171 out of 9,885 | 58th |
Division Manufacturing | 1,481 out of 3,690 | 60th |
Major group Chemicals And Allied Products | 281 out of 866 | 68th |
Industry group Drugs | 168 out of 638 | 74th |
Industry Biological Products, Except Diagnostic Substances | 28 out of 133 | 79th |
Source: SEC filing on March 24, 2011.
Leff's colleagues
We found eight more compensation records of executives who worked with Jonathan A. Leff at Halozyme Therapeutics in 2009.
2009
Kurt Gustafson
Halozyme Therapeutics
Chief Financial Officer
2009
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2009
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2009
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2009
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2009
David Ramsay
Halozyme Therapeutics
Vice President Corporate Development
2009
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2009
Michael LaBarre
Halozyme Therapeutics